Home
overview

Visit the download center to read the exclusive new interview with Hemofarm!

SMi Group is proud to present the 23rd annual industry leading summit on Pharmaceutical Pricing and Market Access, taking place on 11th & 12th October 2017 in Central London.

A surge in the price of drugs has recently been making international headline news adding growing pressure from leading government bodies and patient groups for pharmaceutical companies and manufactures to limit future price increases. Mounting criticism has created a shift in focus for payers to be more cost-effective in their approach to setting budgets and managing costs.

Drawing from over two decades worth of expertise, Pharmaceutical Pricing & Market Access 2017 will address these challenges head on by offering a detailed understanding of the payer landscape and preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical pricing market.

Join us this autumn for exclusive case study insight into how manufactures plan to limit future price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); and discuss what can be done by all stakeholders for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
 

  • Increase compliance and navigate the regulatory landscape through informed guidance presented by the FDA in an opening keynote address
  • Develop strategies for market access and expansion by; defining your target audience; identifying key economic advantages; and generating appropriate clinical and health economic evidence to support a strong value proposition
  • Utilise strategic partnerships by learning best practice in collaborating with payers, data providers and health stakeholders
  • Drive commercial competitiveness by uncovering new windows of opportunity in growing markets such as orphan drugs, biosimilars and gene therapy
  • Make informed decisions from development through to reimbursement by optimising meaningful patient engagement opportunities
  • Explore ways in which the HTA and Regulatory Agencies can work together to meet patient needs
  • Strengthen your strategic capabilities by hearing the latest updates through a selection of global case studies on translational market access, international reference pricing and value based pricing
  • Secure commercial viability by discovering new market access algorithms for innovative drugs
  • Showcase product value by implementing real world data into pricing and utilising Real World Evidence (RWE) for payer decision making

Heads of HTA, Health Economics, Pricing, Pricing & Reimbursement (P&R) and Market Access from pharmaceutical companies, manufacturers and Legal/Health Economics/ Healthcare/ HEOR consultancies

Join our growing community of experts. Previous attendees have included: Acorda Therapeutics, Inc.; Aeterna Zentaris GmbH; Alcon Pharma GmbH; Amgen Inc; Apex Healthcare Consulting Limited; ASFJAEOIL; Association of the British Pharmaceutical Industry (ABPI); Astellas Pharma Europe Ltd; Biogen Idec; Boehringer Ingelheim; Camurus AB; Cell and Gene Therapy Catapult; Clinuvel AG; Convance; Covance Market Access; EUCOPE; Ferring International Center S.A.; IGES Institut; IGES Institut.; IMIC Pharmacuticals; IMS Health; Irish Pharmaceutical Healthcare Association; Janssen Strategic Marketing; Justpharmareports; KoraáHealthcare; Mr; Novartis; Office Of Health Economics; Otsuka Pharmaceuticals Co Limited; Phaidon International; Proceutica; Shire; Teva Pharmaceuticals; The Cystic Fibrosis Trust; Thomson Reuters; Wockhardt UK Ltd;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Patrick Mollon

Patrick Mollon, Director Health-Economics & Outcomes Research, Shire

9:10 The changing pharma environment

Klaas Postema

Klaas Postema, Sr Director Market Access & Pricing Generics Europe, Teva

  • From disease to patient thinking
  • How do we (pharma) keep delivering value to society
  • Can keep measuring value without a holistic view
  • 9:50 Collaborating to bring value in development: What can we do within the constraints of RCTs?

    Anita Burrell

    Anita Burrell, Founder and CEO, Anita Burrell Consulting

  • Understanding the key decision points during development - when is the train already rolling?
  • Putting commercial and market access issues into clinical development decision making - what works?
  • Beyond patient centricity as a concept - what are others doing to really impact the development process with what matters for patients
  • 10:30 Morning Coffee

    11:00 Collaborating with payers to achieve market access

    Fabrizio Zucca

    Fabrizio Zucca, Director Patient Access, Swedish Orphan Biovitrum

  • Aligning contracting with a value-based healthcare system
  • Implementing real-world data to showcase product value
  • Increase in payer confidence of product efficacy
  • 11:40 How can HTA and Regulatory Agencies better meet the needs of patients by ensuring the patient perspective is held paramount

    Anne Marciniak

    Anne Marciniak, Senior Director, International HEOR, Allergan Ltd

  • Ensuring the patient remains in the best interest of everybody
  • How can HTA and regulatory bodies work together to achieve this
  • HTA benefits to date
  • 12:20 Networking Lunch

    13:20 Reimbursement considerations for cell and gene therapies

    Panos Kafalas

    Panos Kafalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult

  • Cell and Gene therapies: what is challenging from a reimbursement perspective
  • Lessons learned so far for securing commercial viability
  • Dealing with data uncertainty
  • 14:00 Rare diseases and orphan drugs: A market access outlook

    Patrick Mollon

    Patrick Mollon, Director Health-Economics & Outcomes Research, Shire

  • A specialized and limited market, however access may be an issue 
  • Evolving funding environment
  • The role of RWE
  •  

    14:40 Afternoon Tea

    15:10 Value based pricing - is it affordable?

    Mercedes Prior

    Mercedes Prior, International Market Access Director, Grifols

  • Cost of the product vs value to the patient
  • What effect would value based pricing have on market access?
  • Is there potential for this strategy?
  • 15:50 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Barbara  Jaszewski

    Barbara Jaszewski, VP Global Pricing and Market Access, Lundbeck Denmark

    9:10 Integrating real-world data into pricing

    Barbara  Jaszewski

    Barbara Jaszewski, VP Global Pricing and Market Access, Lundbeck Denmark

  • Partnerships with health economics teams to gather data
  • Comparative analysis of new products against legacy therapies
  • Development of measures to highlight quality of life
  • Long-term approaches to positioning real-world data
  • 9:50 International Reference Pricing

    Sasa Perovic

    Sasa Perovic, Head of Pharmacoeconomics and Pricing department , Hemofarm

  • Country specific reference pricing update – special review of Southeast Europe
  • The deterioration of the value of the local currencies and the impact of this
  • How seriously are we taking this?
  • 10:30 Morning Coffee

    11:00 How to utilize strategic partnerships for market access purpose in a Finnish setting?

    Ritva Lehtonen

    Ritva Lehtonen, Market access & external affairs director, Sanofi

  • Challenges in strategic partnerships
  • Focus to external and internal elements in Finland
  • Creating alliances with data providers and healthcare stakeholders
  • Enhancing strategic capabilities for all partners through a “win-win” dialogue
  • 11:40 Italian Drug Agency - AIFA- New algorithm for market access of innovative drugs

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

  • The main changes: different levels of innovations and related benefits
  • Pro and cons in valuing a new drug
  • Accessing the new annual 1bn€ special funds and direct inclusion in all Regional formularies
  • How to manage the new method to gain the best benefits in P&R processes
  • 12:20 Networking Lunch

    13:20 Politics, Payers and Pandemonium: An insight into the future UK pricing and market access environment

    John Spoors

    John Spoors, Associate Director, RJW & Partners Ltd
    View Bio

  • Accelerated Access Review (AAR) – an update
  • Current pricing strategies and market access arrangements
  • The future of UK pricing
  • 14:00 Biosimilars – will they have a “chilling” effect on drug prices?

    Steinar Madsen

    Steinar Madsen, Medical Director, Norwegian Medicines Agency

  • Prices – will originators stand their ground or give in to biosimilars?
  • Can new drugs in same therapeutic class maintain high prices in face of lower priced biosimilars?
  • From biosimilar approval to biogenerics in practice?
  • 14:40 Chairman’s Closing Remarks

    14:50 Afternoon Tea and Close of Day Two

    +

    FEATURED SPEAKERS

    Barbara  Jaszewski

    Barbara Jaszewski

    VP Global Pricing and Market Access, Lundbeck Denmark
    Patrick Mollon

    Patrick Mollon

    Director Health-Economics & Outcomes Research, Shire
    Steinar Madsen

    Steinar Madsen

    Medical Director, Norwegian Medicines Agency

    Anita Burrell

    Founder and CEO, Anita Burrell Consulting
    Anita Burrell

    Anne Marciniak

    Senior Director, International HEOR, Allergan Ltd
    Anne Marciniak

    Barbara Jaszewski

    VP Global Pricing and Market Access, Lundbeck Denmark
    Barbara  Jaszewski

    Fabrizio Gianfrate

    Professor of Health Economics, University of Ferrara
    Fabrizio Gianfrate

    Fabrizio Zucca

    Director Patient Access, Swedish Orphan Biovitrum
    Fabrizio Zucca

    Finn Ziegler

    Pricing & market access & public affairs expert, LEO Pharma A/S
    Finn Ziegler

    John Spoors

    Associate Director, RJW & Partners Ltd
    John Spoors

    John has been working at RJW & partners since 2012. He has over 12 years experience in the pharmaceutical sector.

    John started his career in the industry as Policy and Market Access Executive at Merck, Sharp and Dohme, where he was responsible for project managing the company’s UK Health Technology Appraisal (HTA) programmes for diabetes, HIV and oncology, and assisting with policy and public affairs campaigns. He then moved into consultancy with Helen Johnson Consulting Limited (HJCL) as an Account Executive and subsequently as Policy and Market Access Manager, offering clients a tailored service that included HTA advice, tools and project management. He also designed and implemented a HTA monitoring service for a number of major pharmaceutical companies.

    At RJW & partners, John has worked on a wide range of international pricing and market access projects, whilst maintaining his in-depth knowledge and understanding of UK market access and HTA. He has managed projects that cover all major European markets and also conducted projects in specific Latin American and Asian countries. He has developed expertise in a number of orphan diseases and is recognised for his ability to develop payer insights through 1:1 discussions and panel activities.

    John is a regular contributor to journals and conferences, combining his interest in policy, pricing and market access to develop thought-provoking articles on current issues in healthcare.
    John has a degree in Politics and Economics from Manchester University and a Diploma of Higher Education in Natural Sciences from the Open University. He is currently studying for an MSc in Public Health at the London School of Hygiene and Tropical Medicine.
     

    Klaas Postema

    Sr Director Market Access & Pricing Generics Europe, Teva
    Klaas Postema

    Mercedes Prior

    International Market Access Director, Grifols
    Mercedes Prior

    Panos Kafalas

    Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
    Panos Kafalas

    Patrick Mollon

    Director Health-Economics & Outcomes Research, Shire
    Patrick Mollon

    Ritva Lehtonen

    Market access & external affairs director, Sanofi
    Ritva Lehtonen

    Sasa Perovic

    Head of Pharmacoeconomics and Pricing department , Hemofarm
    Sasa Perovic

    Steinar Madsen

    Medical Director, Norwegian Medicines Agency
    Steinar Madsen

    Official Media Partner

    Official Online Media Partners

    Supporters

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    2017 Preliminary Attendee List

    Download

    An Interview with Pharmaceutical Pricing Pioneer, Anita Burrell

    Download

    Q&A with PAREXEL

    Download

    NEW INTERVIEW! P&R in Emerging Markets - A focus on Western Balkan Regions with Hemofarm

    Download

    Media Partners


    PharmaTimes

    Official Media Partner
    http://www.pharmatimes.com/

    PharmaTimes offers a unique blend of news stories, interviews, features, case studies, analysis and comment on the critical issues facing the pharma and healthcare sectors. Our wide editorial lens combined with our editorial philosophy to deliver sharp, informed and entertaining coverage from the perspective of the industry, the payer and the patient, allows PharmaTimes to help kickstart conversations that matter most to our audience of decision makers within pharma and the healthcare profession. PharmaTimes Competitions are a critical facet of our business, providing a unique opportunity for industry to showcase its most talented people in marketing, communications, sales and clinical research. No other competitions offer entrants the chance to compete head-to-head in real-life challenges devised by independent industry and healthcare experts, to test their skill sets against their peers in real time, and receive feedback to ensure the whole experience is a valuable learning process.


    GaBi

    Official Media Partner
    http://www.gabionline.net

    Generics and Biosimilars Initiative (GaBI) was founded in 2008. GaBI aims to foster the worldwide efficient use of high quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable and sustainable health care. The objective of GaBI is to raise the scientific status of generic and biosimilar medicines, via well-documented and up-to-date information about generic and biosimilar medicines both in print (www.gabi-journal.net) and electronically (www.gabionline.net) in an open access format, providing high quality, scientifically sound and reliable information to healthcare professionals including physicians, pharmacists and nurses, consumers, drug developers, third-party payers, legislators and assessors; who are in need of a reliable, critical and independent source of information on all aspects of generic and biosimilar medicines. Subscribe to gain easy access of information on the latest scientific research and developments in generic and biosimilar medicines via GaBI Online to editorial@gabionline.net; or submit a manuscript to GaBI Journal to editorial@gabi-journal.net. GaBI’s mission – Building trust in cost-effective treatments


    FiercePharma

    Official Media Partner
    http://www.fiercepharma.com/

    At FierceMarkets, our mission is as clear today as it was at our founding in 2000: be the first place to turn to for information-hungry executives in dynamic industries and a trusted partner for the marketing teams that need to reach them. Back then, we saw the coming power of blogs, web journalism, digital marketing and email communications, and launched our first email newsletter, FierceWireless, to begin fulfilling that mission for the mobile telecommunications industry. Today, our family of over 100 email newsletter publications and websites carries out that same mission for many more industries and millions of users, while we also evolve to address the latest trends in digital media -- mobile devices, social media, native advertising and content marketing. Regardless of what the next trend may be, however, we remain fiercely committed to independent insights for our readers and marketing success for our customers.

    Media Partners


    BioChem Adda

    Official Online Media Partners
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!

    Media Partners


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    BioPharm Insight

    Supporters
    http://www.biopharminsight.com

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.